These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21880758)

  • 1. A fusion-loop antibody enhances the infectious properties of immature flavivirus particles.
    Rodenhuis-Zybert IA; Moesker B; da Silva Voorham JM; van der Ende-Metselaar H; Diamond MS; Wilschut J; Smit JM
    J Virol; 2011 Nov; 85(22):11800-8. PubMed ID: 21880758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2.
    da Silva Voorham JM; Rodenhuis-Zybert IA; Ayala Nuñez NV; Colpitts TM; van der Ende-Metselaar H; Fikrig E; Diamond MS; Wilschut J; Smit JM
    PLoS One; 2012; 7(3):e29957. PubMed ID: 22431958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. prM-antibody renders immature West Nile virus infectious in vivo.
    Colpitts TM; Rodenhuis-Zybert I; Moesker B; Wang P; Fikrig E; Smit JM
    J Gen Virol; 2011 Oct; 92(Pt 10):2281-2285. PubMed ID: 21697345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional importance of dengue virus maturation: infectious properties of immature virions.
    Zybert IA; van der Ende-Metselaar H; Wilschut J; Smit JM
    J Gen Virol; 2008 Dec; 89(Pt 12):3047-3051. PubMed ID: 19008392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The infectivity of prM-containing partially mature West Nile virus does not require the activity of cellular furin-like proteases.
    Mukherjee S; Lin TY; Dowd KA; Manhart CJ; Pierson TC
    J Virol; 2011 Nov; 85(22):12067-72. PubMed ID: 21880759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus.
    Dowd KA; Jost CA; Durbin AP; Whitehead SS; Pierson TC
    PLoS Pathog; 2011 Jun; 7(6):e1002111. PubMed ID: 21738473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody.
    Cherrier MV; Kaufmann B; Nybakken GE; Lok SM; Warren JT; Chen BR; Nelson CA; Kostyuchenko VA; Holdaway HA; Chipman PR; Kuhn RJ; Diamond MS; Rossmann MG; Fremont DH
    EMBO J; 2009 Oct; 28(20):3269-76. PubMed ID: 19713934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immature dengue virus: a veiled pathogen?
    Rodenhuis-Zybert IA; van der Schaar HM; da Silva Voorham JM; van der Ende-Metselaar H; Lei HY; Wilschut J; Smit JM
    PLoS Pathog; 2010 Jan; 6(1):e1000718. PubMed ID: 20062797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis.
    Dowd KA; Sirohi D; Speer SD; VanBlargan LA; Chen RE; Mukherjee S; Whitener BM; Govero J; Aleshnick M; Larman B; Sukupolvi-Petty S; Sevvana M; Miller AS; Klose T; Zheng A; Koenig S; Kielian M; Kuhn RJ; Diamond MS; Pierson TC
    Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2218899120. PubMed ID: 36638211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of a monoclonal antibody against prM protein of West Nile virus.
    Guo LP; Huo H; Wang XL; Bu ZG; Hua RH
    Monoclon Antib Immunodiagn Immunother; 2014 Dec; 33(6):438-43. PubMed ID: 25514166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization.
    Nelson S; Jost CA; Xu Q; Ess J; Martin JE; Oliphant T; Whitehead SS; Durbin AP; Graham BS; Diamond MS; Pierson TC
    PLoS Pathog; 2008 May; 4(5):e1000060. PubMed ID: 18464894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus.
    Elshuber S; Allison SL; Heinz FX; Mandl CW
    J Gen Virol; 2003 Jan; 84(Pt 1):183-191. PubMed ID: 12533715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.
    Goo L; Debbink K; Kose N; Sapparapu G; Doyle MP; Wessel AW; Richner JM; Burgomaster KE; Larman BC; Dowd KA; Diamond MS; Crowe JE; Pierson TC
    Nat Microbiol; 2019 Jan; 4(1):71-77. PubMed ID: 30455471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing dengue virus maturation using a stable furin over-expressing cell line.
    Mukherjee S; Sirohi D; Dowd KA; Chen Z; Diamond MS; Kuhn RJ; Pierson TC
    Virology; 2016 Oct; 497():33-40. PubMed ID: 27420797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Enhanced Immature Dengue Virus Attachment to Endosomal Membrane Induced by prM Antibody.
    Wirawan M; Fibriansah G; Marzinek JK; Lim XX; Ng TS; Sim AYL; Zhang Q; Kostyuchenko VA; Shi J; Smith SA; Verma CS; Anand G; Crowe JE; Bond PJ; Lok SM
    Structure; 2019 Feb; 27(2):253-267.e8. PubMed ID: 30471923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction.
    Junjhon J; Lausumpao M; Supasa S; Noisakran S; Songjaeng A; Saraithong P; Chaichoun K; Utaipat U; Keelapang P; Kanjanahaluethai A; Puttikhunt C; Kasinrerk W; Malasit P; Sittisombut N
    J Virol; 2008 Nov; 82(21):10776-91. PubMed ID: 18715923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection.
    Wang Y; Si LL; Guo XL; Cui GH; Fang DY; Zhou JM; Yan HJ; Jiang LF
    Virus Res; 2017 Feb; 229():57-64. PubMed ID: 27939945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage.
    Keelapang P; Nitatpattana N; Suphatrakul A; Punyahathaikul S; Sriburi R; Pulmanausahakul R; Pichyangkul S; Malasit P; Yoksan S; Sittisombut N
    Vaccine; 2013 Oct; 31(44):5134-40. PubMed ID: 23973247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.